| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 19.144 | 20.437 | 22.093 | 19.407 | 18.338 | 16.560 | 18.173 | 20.864 | 18.008 | 19.205 |
| Total Income - EUR | 21.039 | 21.249 | 23.311 | 20.590 | 19.793 | 17.732 | 18.173 | 20.864 | 22.273 | 19.853 |
| Total Expenses - EUR | 18.393 | 15.355 | 15.585 | 12.694 | 13.318 | 10.874 | 12.264 | 22.956 | 23.015 | 20.075 |
| Gross Profit/Loss - EUR | 2.646 | 5.894 | 7.727 | 7.896 | 6.476 | 6.858 | 5.909 | -2.092 | -743 | -222 |
| Net Profit/Loss - EUR | 2.028 | 4.770 | 6.222 | 7.278 | 5.882 | 6.349 | 5.413 | -2.718 | -1.460 | -869 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Amelco Med S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 6.710 | 6.641 | 6.529 | 6.409 | 6.259 | 6.140 | 6.004 | 26.171 | 19.577 | 12.989 |
| Current Assets | 24.755 | 26.743 | 31.255 | 37.674 | 43.043 | 48.361 | 52.781 | 30.368 | 35.607 | 40.601 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 5.300 | 3.342 | 4.808 | 953 | 3.789 | 5.084 | 5.637 | 5.899 | 3.446 | 3.243 |
| Cash | 3.460 | 7.096 | 10.178 | 20.425 | 22.434 | 26.175 | 30.573 | 7.845 | 13.674 | 18.502 |
| Shareholders Funds | 26.243 | 30.745 | 36.446 | 43.056 | 48.104 | 53.541 | 57.767 | 55.229 | 53.601 | 52.432 |
| Social Capital | 4.499 | 4.454 | 4.378 | 4.298 | 4.215 | 4.135 | 4.043 | 4.056 | 4.043 | 4.021 |
| Debts | 5.348 | 2.774 | 1.431 | 1.112 | 1.261 | 960 | 1.018 | 1.447 | 1.658 | 1.218 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7022 - 7022" | |||||||||
| CAEN Financial Year |
7022
|
|||||||||
Comments - Amelco Med S.r.l.